Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Hypertension. 2008 Nov 3;52(6):1134–1141. doi: 10.1161/HYPERTENSIONAHA.108.121582

Fig. 8.

Fig. 8

Effect of intravenous administration of the Tat fusion proteins on the urinary excretion of NOx in vivo (n = 4 rats in each group). Tat-AP and Tat-PBM decreased NOx/creatinine levels to that observed in the rats that received the 0.3% NaCl diet. *P < 0.05 compared to the remaining 6 groups; †P > 0.05 compared to the group that received the 0.3% NaCl diet and vehicle (Veh)